IBDEI0YE ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16980,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16980,1,4,0)
 ;;=4^307.41
 ;;^UTILITY(U,$J,358.3,16980,1,5,0)
 ;;=5^Insomnia, Nonorganic, Transient
 ;;^UTILITY(U,$J,358.3,16980,2)
 ;;=^268285
 ;;^UTILITY(U,$J,358.3,16981,0)
 ;;=780.52^^92^945^100
 ;;^UTILITY(U,$J,358.3,16981,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16981,1,4,0)
 ;;=4^780.52
 ;;^UTILITY(U,$J,358.3,16981,1,5,0)
 ;;=5^Insomnia, Organic
 ;;^UTILITY(U,$J,358.3,16981,2)
 ;;=Insomnia, Organic^87662
 ;;^UTILITY(U,$J,358.3,16982,0)
 ;;=302.71^^92^945^103
 ;;^UTILITY(U,$J,358.3,16982,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16982,1,4,0)
 ;;=4^302.71
 ;;^UTILITY(U,$J,358.3,16982,1,5,0)
 ;;=5^Loss of Libido
 ;;^UTILITY(U,$J,358.3,16982,2)
 ;;=^268178
 ;;^UTILITY(U,$J,358.3,16983,0)
 ;;=785.6^^92^945^106
 ;;^UTILITY(U,$J,358.3,16983,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16983,1,4,0)
 ;;=4^785.6
 ;;^UTILITY(U,$J,358.3,16983,1,5,0)
 ;;=5^Lymphadenopathy
 ;;^UTILITY(U,$J,358.3,16983,2)
 ;;=Lymphadenopathy^72368
 ;;^UTILITY(U,$J,358.3,16984,0)
 ;;=728.85^^92^945^112
 ;;^UTILITY(U,$J,358.3,16984,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16984,1,4,0)
 ;;=4^728.85
 ;;^UTILITY(U,$J,358.3,16984,1,5,0)
 ;;=5^Muscle Spasm
 ;;^UTILITY(U,$J,358.3,16984,2)
 ;;=Muscle Spasm^112558
 ;;^UTILITY(U,$J,358.3,16985,0)
 ;;=782.0^^92^945^51
 ;;^UTILITY(U,$J,358.3,16985,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16985,1,4,0)
 ;;=4^782.0
 ;;^UTILITY(U,$J,358.3,16985,1,5,0)
 ;;=5^Disturbance of Skin Sensation
 ;;^UTILITY(U,$J,358.3,16985,2)
 ;;=Disturbance of Skin Sensation^35757
 ;;^UTILITY(U,$J,358.3,16986,0)
 ;;=278.00^^92^945^117
 ;;^UTILITY(U,$J,358.3,16986,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16986,1,4,0)
 ;;=4^278.00
 ;;^UTILITY(U,$J,358.3,16986,1,5,0)
 ;;=5^Obesity
 ;;^UTILITY(U,$J,358.3,16986,2)
 ;;=Obesity^84823
 ;;^UTILITY(U,$J,358.3,16987,0)
 ;;=278.01^^92^945^118
 ;;^UTILITY(U,$J,358.3,16987,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16987,1,4,0)
 ;;=4^278.01
 ;;^UTILITY(U,$J,358.3,16987,1,5,0)
 ;;=5^Obesity, Morbid
 ;;^UTILITY(U,$J,358.3,16987,2)
 ;;=Obesity, Morbid^84844
 ;;^UTILITY(U,$J,358.3,16988,0)
 ;;=783.5^^92^945^127
 ;;^UTILITY(U,$J,358.3,16988,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16988,1,4,0)
 ;;=4^783.5
 ;;^UTILITY(U,$J,358.3,16988,1,5,0)
 ;;=5^Polydipsia
 ;;^UTILITY(U,$J,358.3,16988,2)
 ;;=Polydipsia^186699
 ;;^UTILITY(U,$J,358.3,16989,0)
 ;;=783.6^^92^945^128
 ;;^UTILITY(U,$J,358.3,16989,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16989,1,4,0)
 ;;=4^783.6
 ;;^UTILITY(U,$J,358.3,16989,1,5,0)
 ;;=5^Polyphagia
 ;;^UTILITY(U,$J,358.3,16989,2)
 ;;=Polyphagia^60236
 ;;^UTILITY(U,$J,358.3,16990,0)
 ;;=780.2^^92^945^144
 ;;^UTILITY(U,$J,358.3,16990,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16990,1,4,0)
 ;;=4^780.2
 ;;^UTILITY(U,$J,358.3,16990,1,5,0)
 ;;=5^Syncope and Collapse
 ;;^UTILITY(U,$J,358.3,16990,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,16991,0)
 ;;=783.1^^92^945^156
 ;;^UTILITY(U,$J,358.3,16991,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16991,1,4,0)
 ;;=4^783.1
 ;;^UTILITY(U,$J,358.3,16991,1,5,0)
 ;;=5^Weight gain, abnormal
 ;;^UTILITY(U,$J,358.3,16991,2)
 ;;=^998
 ;;^UTILITY(U,$J,358.3,16992,0)
 ;;=783.21^^92^945^157
 ;;^UTILITY(U,$J,358.3,16992,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16992,1,4,0)
 ;;=4^783.21
 ;;^UTILITY(U,$J,358.3,16992,1,5,0)
 ;;=5^Weight loss, abnormal
 ;;^UTILITY(U,$J,358.3,16992,2)
 ;;=^322005
 ;;^UTILITY(U,$J,358.3,16993,0)
 ;;=796.2^^92^945^32
 ;;^UTILITY(U,$J,358.3,16993,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16993,1,4,0)
 ;;=4^796.2
